FdaApplication
BLA 761400
Identifiers
- fda_app_no: BLA761400
Properties
| Property | Value |
|---|---|
| applicant_name | Regeneron Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2025-07-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYNOZYFIC | LINVOSELTAMAB-GCPT | 5MG/2.5ML (2MG/ML) | SOLUTION;INJECTION |
| LYNOZYFIC | — | 200MG/10ML (20MG/ML) | Injection |
2 products